These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1578205)

  • 1. The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis.
    Mold JW; Holtgrave DR; Bisonni RS; Marley DS; Wright RA; Spann SJ
    J Fam Pract; 1992 May; 34(5):561-8. PubMed ID: 1578205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer screening: a decision analysis.
    Cantor SB; Spann SJ; Volk RJ; Cardenas MP; Warren MM
    J Fam Pract; 1995 Jul; 41(1):33-41. PubMed ID: 7798064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
    Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Parnes HL; Lippman SM; Coltman CA
    J Urol; 2007 May; 177(5):1749-52. PubMed ID: 17437804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores.
    Naughton CK; Miller DC; Yan Y
    J Urol; 2001 Jan; 165(1):100-3. PubMed ID: 11125374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minority issues in prostate disease.
    French DB; Jones LA
    Med Clin North Am; 2005 Jul; 89(4):805-16. PubMed ID: 15925651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer. When to offer screening in the primary care setting.
    Gambert SR
    Geriatrics; 2001 Jan; 56(1):22-6, 29-31. PubMed ID: 11196336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of utilities for health states in early stage prostate cancer.
    Saigal CS; Gornbein J; Nease R; Litwin MS
    J Urol; 2001 Sep; 166(3):942-6. PubMed ID: 11490251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
    Aus G
    Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].
    Soulié M; Villers A; Richaud P; Prapotnich D; Ruffion A; Grosclaude P
    Prog Urol; 2001 Dec; 11(6):1195-204. PubMed ID: 11859652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision analyses in consideration of treatment strategies for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era.
    Shimizu F; Igarashi A; Fukuda T; Kawachi Y; Minowada S; Ohashi Y; Fujime M
    Jpn J Clin Oncol; 2007 Oct; 37(10):763-74. PubMed ID: 17956899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
    Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
    CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.
    Sommers BD; Beard CJ; D'Amico AV; Dahl D; Kaplan I; Richie JP; Zeckhauser RJ
    Cancer; 2007 Nov; 110(10):2210-7. PubMed ID: 17893907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interim determination of health gain from oral cancer and precancer screening: 2. Developing a model of population screening.
    Downer MC; Jullien JA; Speight PM
    Community Dent Health; 1997 Dec; 14(4):227-32. PubMed ID: 9458580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of cancer of the prostate. A study of 600 cases].
    Teillac P; Bron J; Tobolski F; Cussenot O; Lesourd A; Leroy M; Toubert ME; Brocheriou C; Laval-Jeantet M; Le Duc A
    Ann Urol (Paris); 1990; 24(1):37-41. PubMed ID: 1690963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer Tx. Therapeutic options based on tumor grade, life expectancy, and patient preferences.
    Cohen SP; Jaskulsky SR
    Geriatrics; 2001 Feb; 56(2):39, 42, 47-8 passim. PubMed ID: 11219024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active surveillance for the management of prostate cancer in a contemporary cohort.
    Dall'Era MA; Konety BR; Cowan JE; Shinohara K; Stauf F; Cooperberg MR; Meng MV; Kane CJ; Perez N; Master VA; Carroll PR
    Cancer; 2008 Jun; 112(12):2664-70. PubMed ID: 18433013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.